Cohort of patients with ischemic stroke
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke.
This study looks at patients who have had an ischemic stroke to see if new tests can help predict how they will respond to treatment and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Trial ID | NCT03149705 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have experienced an ischemic stroke, which is a leading cause of disability and death. The study aims to collect clinical, laboratory, and imaging data to identify new biological and imaging markers that could predict treatment response and prognosis. By establishing a comprehensive clinical database, the research seeks to enhance the understanding of ischemic stroke and improve patient care. The cohort will provide valuable insights for future research and interventions in stroke management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have a confirmed ischemic stroke and are eligible for thrombolysis or thrombectomy.
Not a fit: Patients with progressive or uncontrolled cancer, or those residing more than 50 km from the study location, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for patients suffering from ischemic stroke.
How similar studies have performed: While cohorts of stroke patients are rare, similar studies have shown promise in identifying biomarkers and improving treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age\> 18 years * Ischemic Stroke confirmed by MRI * Proximal arterial occlusion (ICA or M1) * Eligible for thrombolysis and/or thrombectomy Exclusion Criteria: * Patients residing\> 50 km from the Pierre Wertheimer Hospital (Lyon, France) * Inability to perform the first sample (H0) * Patient with progressive or uncontrolled cancer. * Refusal to participate in the study or to sign the consent * Lack of medical social coverage * Deprivation of civil rights
Where this trial is running
Bron
- Hôpital neurologique Pierre Wertheimer (Lyon) — Bron, France (Recruiting)
Study contacts
- Study coordinator: Norbert NIGHOGHOSSIAN, Prof
- Email: GHE.CICLYON@chu-lyon.fr
- Phone: +33 4 72 35 71 70
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.